NASDAQ:PTPI

Petros Pharmaceuticals Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy PTPI

*Your capital is at risk

$0.0030

-0.0006 (-16.67%)

At Close: Jul 31, 2026

Petros Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 27.3M and sold 0 PTPI shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	27.3M shares
● Sell	0 shares
100% Buy Activity Strong Negative Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 07, 2022 Buy	Restricted Stock Units A-Award	Bradley Greg	Director	60 505 Value: $0
Apr 07, 2022 Buy	Restricted Stock Units A-Award	Bernstein Bruce	Director	60 505 Value: $0
Apr 07, 2022 Buy	Restricted Stock Units A-Award	Walker Wayne Remell	Director	60 505 Value: $0
Apr 07, 2022 Buy	Restricted Stock Units A-Award	Silverman Joshua	Director	67 227 Value: $0
Apr 07, 2022 Buy	Restricted Stock Units A-Award	Bradley Greg	Director	60 505 Value: $0
Apr 07, 2022 Buy	Restricted Stock Units A-Award	Bernstein Bruce	Director	60 505 Value: $0
Dec 22, 2021 Buy	Restricted Stock Units A-Award	Walker Wayne Remell Director	Director	22 642 Value: $0
Dec 22, 2021 Buy	Restricted Stock Units A-Award	Silverman Joshua Director	Director	25 156 Value: $0
Dec 22, 2021 Buy	Restricted Stock Units A-Award	Bradley Greg Director	Director	22 642 Value: $0
Dec 22, 2021 Buy	Restricted Stock Units A-Award	Bernstein Bruce Director	Director	22 642 Value: $0
Dec 22, 2021 Buy	Restricted Stock Units A-Award	Walker Wayne Remell Director	Director	22 642 Value: $0
Dec 22, 2021 Buy	Restricted Stock Units A-Award	Silverman Joshua Director	Director	25 156 Value: $0
Dec 22, 2021 Buy	Restricted Stock Units A-Award	Bradley Greg Director	Director	22 642 Value: $0
Dec 22, 2021 Buy	Restricted Stock Units A-Award	Bernstein Bruce Director	Director	22 642 Value: $0
Dec 22, 2021 Buy	Common Stock, par value $0.0001 per share P-Purchase	Shulman John D	Director	145 773 Value: $500.0K
Dec 22, 2021 Buy	Warrant P-Purchase	Shulman John D	Director	109 329 Value: $382.7K
Dec 22, 2021 Buy	Common Stock, par value $0.0001 per share P-Purchase	Shulman John D	Director	145 773 Value: $500.0K
Dec 22, 2021 Buy	Warrant P-Purchase	Shulman John D	Director	109 329 Value: $382.7K
Nov 29, 2021 Buy	Common Stock, par value $0.0001 per share P-Purchase	Shulman John D	Director	500 000 Value: $1.50M
Nov 29, 2021 Buy	Warrant P-Purchase	Shulman John D	Director	375 000 Value: $1.31M
Nov 29, 2021 Buy	Common Stock, par value $0.0001 per share P-Purchase	Shulman John D	Director	500 000 Value: $1.50M
Nov 29, 2021 Buy	Warrant P-Purchase	Shulman John D	Director	375 000 Value: $1.31M
Oct 18, 2021 Buy	Common Stock, par value $0.0001 per share P-Purchase	Shulman John D	Director	1 661 807 Value: $2.85M
Oct 18, 2021 Buy	Warrant P-Purchase	Shulman John D	Director	1 661 807 Value: $2.85M
Oct 18, 2021 Buy	Common Stock, par value $0.0001 per share P-Purchase	Shulman John D	Director	1 661 807 Value: $2.85M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT PETROS PHARMACEUTICALS INC

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vac...

Read Full Profile Here